Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-Related Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00001049
What this trial is testing

Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 180
Large-scale testing (Phase 3)UnknownNCT01216800
What this trial is testing

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors

Who this might be right for
Head and Neck CancerOtotoxicityRadiation Toxicity
Institute of Cancer Research, United Kingdom 84
Testing effectiveness (Phase 2)Looking for participantsNCT04711200
What this trial is testing

LYell SYndrome MEsenchymal Stromal Cells Treatment

Who this might be right for
Epidermal NecrolysisLyell SyndromeToxic Epidermal Necrolysis+3 more
Assistance Publique - Hôpitaux de Paris 15
Not applicableStudy completedNCT03131024
What this trial is testing

Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects

Who this might be right for
Breast Cancer Female
University of Alberta 58
Not applicableStudy completedNCT05923242
What this trial is testing

Translating ECHOS2 Into an mHealth Platform

Who this might be right for
Childhood CancerCardiac ToxicityPediatric Cancer
Washington University School of Medicine 73
Testing effectiveness (Phase 2)Study completedNCT00006012
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerRadiation Toxicity
Alliance for Clinical Trials in Oncology 73
Not applicableLooking for participantsNCT01194648
What this trial is testing

Focal Therapy for Prostate Cancer Using HIFU

Who this might be right for
Male Erectile DisorderProstate CancerTherapy-related Toxicity+1 more
University College, London 354
Testing effectiveness (Phase 2)Ended earlyNCT02037347
What this trial is testing

Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal NecrolysisStevens-Johnson Syndrome
Brett King 1
Not applicableStudy completedNCT03603158
What this trial is testing

KCNH2 Polymorphisms on the QTc Interval in Kelantanese Malays Patients Receiving Methadone Maintenance Therapy (MMT)

Who this might be right for
Opioid DependenceMethadone ToxicityHERG Gene Mutation
Universiti Sains Malaysia 111
Post-approval studies (Phase 4)UnknownNCT02957864
What this trial is testing

Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide

Who this might be right for
Renal Insufficiency,ChronicHivTherapeutic Agent Toxicity
Erasmus Medical Center 80
Not applicableActive Not RecruitingNCT03199300
What this trial is testing

Investigating Cardiovascular Adverse Events Related to Cancer Treatment

Who this might be right for
Toxicity Due to ChemotherapyCardiovascular MorbidityCancer, Treatment-Related
University Medical Center Groningen 20
Large-scale testing (Phase 3)Ended earlyNCT00006994
What this trial is testing

S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat

Who this might be right for
Cancer-related Problem/ConditionHead and Neck CancerPain
SWOG Cancer Research Network 23
Not applicableStudy completedNCT07073807
What this trial is testing

Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy

Who this might be right for
CancerNeoplasms
University of California, Irvine 35
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Not applicableLooking for participantsNCT07491536
What this trial is testing

Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis

Who this might be right for
Oral MucositisChemotherapy-induced Oral MucositisHead and Neck Neoplasms
University of Pavia 50
Testing effectiveness (Phase 2)Looking for participantsNCT05256745
What this trial is testing

RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer

Who this might be right for
Cancer Related Cognitive DeclineNon-metastatic Breast Cancer
Georgetown University 48
Not applicableLooking for participantsNCT07010939
What this trial is testing

Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients

Who this might be right for
Breast NeoplasmsQuality of Life (QOL)Toxicities+1 more
FangYi 3,000
Testing effectiveness (Phase 2)Study completedNCT00004176
What this trial is testing

Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerRadiation Toxicity
Washington University School of Medicine 34
Not applicableUnknownNCT06383325
What this trial is testing

Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment

Who this might be right for
Liver Toxicity, Chemically-Induced
Assiut University 70
Not applicableEnrolling By InvitationNCT07499128
What this trial is testing

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Who this might be right for
Cytokine Release SyndromeNeoplasmsLymphoma+13 more
National Cancer Institute (NCI) 136
Next Page